Optimize Financial’s Design Therapeutics DSGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$400K Buy
+31,814
New +$440K 0.08% 229

Other funds holding DSGN

Optimize Financial's DSGN Position: Q3 2026 in Review

Optimize Financial opened a new position in Design Therapeutics (DSGN) in Q3 2026: 31,814 shares worth $400K. The stake represents 0.08% of the portfolio and ranks #229 among its holdings.

142 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.

  • Optimize Financial held 31,814 shares of Design Therapeutics worth $400K as of Q3 2026.
  • Design Therapeutics was a new Optimize Financial position in Q3 2026.
  • Design Therapeutics made up 0.08% of Optimize Financial's portfolio in Q3 2026, its #229 holding.
  • 142 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.

Based on Optimize Financial's 13F filing for Q3 2026, filed 12 Nov 2026.